公司資料
Organogenesis 股價、新聞與催化劑
- 股票代碼:
- ORGO
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
1.72 USD (-3.91%)
收盤價
最後更新: 2026年8月17日
288M USD
市值
股價為何變動
As of Aug 17, 2026, ORGO closed down 3.91% at $1.72. No new same-company headline was identified in the current news window.
公司概覽
Regenerative Medicine
Organogenesis develops and manufactures regenerative-medicine products used to support healing in difficult wounds and surgical procedures.
Advanced Wound Care
The company's wound-care portfolio includes cellular and tissue-based products, placental-derived products and other biologic matrices used in chronic and complex wounds.
Surgical and Sports Medicine
Organogenesis also supplies products for orthopedic, sports-medicine and surgical applications, where its biologic materials are used to support soft-tissue repair and healing.
未來催化劑
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。